The post Hyperliquid Debuts Licensed S&P 500 Perpetual Market appeared on BitcoinEthereumNews.com. TLDR S&P Dow Jones Indices licensed the S&P 500 to Trade[XYZ]The post Hyperliquid Debuts Licensed S&P 500 Perpetual Market appeared on BitcoinEthereumNews.com. TLDR S&P Dow Jones Indices licensed the S&P 500 to Trade[XYZ]

Hyperliquid Debuts Licensed S&P 500 Perpetual Market

For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • S&P Dow Jones Indices licensed the S&P 500 to Trade[XYZ] for perpetual trading.
  • Hyperliquid launched the first perpetual contract based on the S&P 500 benchmark.
  • The product allows 24 7 trading without a fixed expiry date.
  • Traders can take leveraged long or short positions at any time.
  • The contract uses institutional quality data sourced directly from S&P DJI.
  • Trade[XYZ] has processed over $100 billion in trading volume since October 2025.

S&P Dow Jones Indices has licensed the S&P 500 to Trade[XYZ] for perpetual contracts. As a result, Hyperliquid now lists the first perpetual product based on the benchmark. The launch enables 24/7 trading using official S&P DJI data within a digital market structure.

Hyperliquid Lists Licensed S&P 500 Perpetual Contract

S&P Dow Jones Indices granted Trade[XYZ] a license to use the S&P 500 for perpetual trading. Consequently, Hyperliquid introduced the first perpetual contract tied to the benchmark. The product allows continuous trading without a fixed expiry date.

Traders can take leveraged long or short positions at any time. Unlike traditional futures, the contract does not require rollover before expiration. The platform sources institutional-quality index data directly from S&P DJI.

The S&P 500 tracks 500 leading United States companies across sectors. The index serves as the primary equity benchmark for global markets. It underpins futures, options, exchange-traded funds, and structured products.

These linked products generate more than $1 trillion in daily volume. Therefore, the perpetual contract connects digital traders to a widely used benchmark. Hyperliquid provides access through its native interface and partner platforms.

The XYZ protocol governs leverage limits and oracle integrations. It also manages market listings and operational parameters. As a result, the system maintains structured oversight of on-chain perpetual markets.

Trade[XYZ] Expands On-Chain Access to Benchmark Markets

Trade[XYZ] operates as an on-chain protocol for perpetual markets linked to real-world assets. Since October 2025, the platform has processed over $100 billion in trading volume. It reports a projected annualized run rate above $600 billion.

Collins Belton, Chief Operating Officer and General Counsel of Trade[XYZ]’s parent company, addressed the launch. He stated, “We developed XYZ with a vision of bringing the world’s most important markets on-chain.” He added that the S&P 500 represents the most widely tracked equity index globally.

Belton said the benchmark has defined global equities for decades. He explained that the partnership makes the S&P 500 fully accessible on Hyperliquid. He linked the launch to the protocol’s mission to digitize core financial markets.

Cameron Drinkwater, Chief Product and Operations Officer at S&P Dow Jones Indices, also commented. He said the collaboration broadens access to S&P DJI benchmarks in digital markets. He emphasized expectations for institutional-grade standards in digital trading.

Drinkwater stated, “This collaboration expands access and utility of our flagship benchmarks within digital trading environments.” He added that digitally native investors should demand institutional-quality standards. He confirmed that S&P DJI supports the integration with Trade[XYZ].

The S&P 500 anchors a global ecosystem of linked exposures. Those markets span futures, options, ETFs, and structured products. The perpetual contract now extends that benchmark access to 24/7 on-chain trading on Hyperliquid.

The post Hyperliquid Debuts Licensed S&P 500 Perpetual Market appeared first on Blockonomi.

Source: https://blockonomi.com/hyperliquid-debuts-licensed-sp-500-perpetual-market/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26